Table 2.
Predictors of Asking Partners About PrEP Use Among 965 Men Living with HIV Reporting HIV-Negative Male Sexual Partners Across 2,580 Total 3 Month Periods
| Within Persons/Time-Varying | OR (SE) | p | AOR (SE) | p |
|---|---|---|---|---|
| Time | 1.06 (0.06) | .35 | 1.16 (0.08) | .02 |
| Heavy alcohol use before/during sex | 1.10 (0.08) | .19 | 1.03 (0.08) | .74 |
| Stimulant use before/during sex | 2.26 (0.66) | .005 | 1.42 (0.40) | .22 |
| Other drug use before/during sex | 1.80 (0.42) | .012 | 1.53 (0.37) | .08 |
| Number of male sexual partners (ln) | 3.06 (0.64) | <.001 | 2.89 (0.68) | <.001 |
| Engagement in group sex | 2.86 (0.57) | <.001 | 1.99 (0.43) | .001 |
| Personal responsibility | 1.00 (0.15) | .98 | 1.09 (0.17) | .58 |
| Antiretroviral therapy (ART) adherence | 0.74 (0.15) | .14 | 0.73 (0.16) | .14 |
| Disclosure to all recent partners | 1.01 (0.21) | .99 | 1.29 (0.29) | .25 |
| Disclosure self-efficacy | 1.11 (0.14) | .40 | 1.04 (0.13) | .73 |
| R2 within | 0.07 (0.02) | <.001 | ||
| Between Persons/Person-Level | β (SE) | p | β (SE) | p |
| Age | −0.01 (0.04) | .90 | −0.18 (0.05) | <.001 |
| Race/ethnicity (ref: White) | ||||
| Black | −0.76 (0.10) | <.001 | −0.29 (0.10) | .003 |
| Latinx | −0.23 (0.11) | .03 | −0.03 (0.10) | .76 |
| Education (BL) | 0.20 (0.04) | <.001 | 0.08 (0.04) | .051 |
| Employed full-time (BL) | −0.001 (0.09) | .99 | −0.12 (0.09) | .18 |
| Income (BL) | 0.18 (0.04) | <.001 | 0.12 (0.05) | .02 |
| City size (BL) | 0.22 (0.04) | <.001 | 0.07 (0.04) | .048 |
| Years living with HIV | −0.01 (0.04) | .83 | 0.04 (0.05) | .45 |
| Heavy alcohol use before/during sex (average) | 0.03 (0.04) | .54 | 0.02 (0.04) | .59 |
| Stimulant use before/during sex (average) | 0.22 (0.04) | <.001 | −0.01 (0.04) | .77 |
| Other drug use before/during sex (average) | 0.31 (0.04) | <.001 | 0.11 (0.04) | .002 |
| Number of male sexual partners (ln average) | 0.61 (0.03) | <.001 | 0.48 (0.05) | <.001 |
| Engagement in group sex (average) | 0.49 (0.04) | <.001 | 0.07 (0.05) | .12 |
| HIV knowledge (BL) | 0.13 (0.04) | .004 | 0.04 (0.03) | .26 |
| Personal responsibility (average) | −0.26 (0.04) | <.001 | −0.04 (0.04) | .30 |
| Antiretroviral therapy (ART) adherence (average) | 0.06 (0.04) | .14 | 0.01 (0.04) | .71 |
| Undetectable viral load (BL) | 0.38 (0.11) | <.001 | 0.25 (0.09) | .007 |
| HIV stigma (3mo) | 0.02 (0.04) | .74 | 0.07 (0.04) | .051 |
| Disclosure to all recent partners (average) | 0.17 (0.04) | <.001 | 0.22 (0.04) | <.001 |
| Disclosure self-efficacy (average) | 0.25 (0.04) | <.001 | 0.06 (0.04) | .17 |
| R2 between | 0.53 (0.04) | <.001 |
Notes. Within predictors are group-mean centered; between predictors are grand-mean centered. Odds ratios (ORs, within level) or standardized regression coefficients (βs, between level) are reported. For binary predictors on the between level, we report STDY estimates from Mplus, which can be interpreted as the change in the outcome variable in standard deviation units when the categorical covariate changes from zero to one (Muthén & Muthén, 1998–2015).